Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) Groundbreaking Delivery Technology Could Revolutionize the CBD Industry
May 31st, 2019
Fueled by an explosion of CBD-infused edibles, billion-dollar projections for the CBD market may even be conservative.
This seems possible when one considers the truly innovative work being done in the sector by the likes of Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), which has developed a patented delivery technology with disruptive potential, delivering 475% more CBD to the bloodstream after 15 minutes than conventional formulations. Other sector innovators are making a similar impact, including the likes of noted cannabinoid biopharma GW Pharmaceuticals Plc (NASDAQ: GWPH) (OTC: GWPRF) and that of researchers and product developers Tilray Inc. (NASDAQ: TLRY), MariMed Inc. (OTCQB: MRMD) and Aurora Cannabis Inc. (TSX: ACB) (NYSE: ACB).